Core Viewpoint - BGM Group Ltd. has received a notification from Nasdaq regarding non-compliance with listing rules due to the late filing of its Annual Report on Form 20-F for the fiscal year ended September 30, 2025 [1][2]. Compliance and Regulatory Actions - The company has 60 calendar days to submit a plan to Nasdaq to regain compliance, with a potential extension of up to 180 days if the plan is accepted [2]. - If the plan is not accepted, the company can appeal the decision to a Hearing Panel, but the notification does not immediately affect the listing of its class A ordinary shares [3]. Company Operations and Focus - BGM Group Ltd. focuses on technology fields including AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [5]. - In AI applications, the company utilizes advanced analytics and AI Agent technology to provide solutions for insurance companies, covering areas such as sales, underwriting, claims processing, and customer service [6]. - The biopharmaceutical division produces oxytetracycline API, crude heparin sodium, and licorice preparations, integrating AI-assisted decision-making to optimize supply chains and improve process efficiency [7].

Company Overview - BGM Group Ltd. is a leading AI technology company focused on AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [5] - The company utilizes advanced analytics and AI agent technology to provide comprehensive AI solutions and intelligent robot services, particularly in the insurance sector [6] Acquisition Details - BGM Group has entered into a definitive agreement to acquire HM Management Company Limited for approximately RMB300 million (US$41.7 million) in an all-stock transaction [1][2] - The acquisition involves issuing 16,663,427 Class A ordinary shares at $2.50 per share to gain 100% ownership of HM Management and its subsidiaries [2] Strategic Impact - The acquisition of Shuda Technology and New Media Star enhances BGM's AI application portfolio and integrates existing resources from its AI insurance and mobility businesses [4] - Shuda Technology specializes in AI-driven enterprise efficiency solutions, while New Media Star operates a growing AI tools platform [3] - The addition of these companies is expected to foster technological creativity and drive industry-wide impact, positioning BGM for rapid expansion into market opportunities [4] Industry Positioning - BGM aims to create a leading ecosystem of AI agent applications, leveraging over 100 industry-specific AI modules and an established developer ecosystem [4] - The company’s biopharmaceutical division integrates AI-assisted decision-making to optimize supply chains and improve process efficiency [7]

Core Viewpoint - BGM Group Ltd is undergoing a significant leadership transition aimed at enhancing its technological transformation and sustainable growth, with a focus on innovation and strategic upgrades in response to market opportunities and challenges [1][5]. Leadership Changes - Mr. Zhanchang Xin has resigned as Chairman, effective March 1, 2025, and will be succeeded by Mr. Chen Xin, the current CEO [2][3]. - Mr. Chen Xin has extensive experience in market consolidation and corporate management, having led the acquisition of Duxiaobao Intelligent Technology and previously worked in autonomous driving algorithm development [3][4]. - Mr. Lin Zhang has been appointed as an independent director and will chair the compensation committee, bringing rich experience in AI model architecture and deep learning projects [4][5]. Strategic Focus - The company is strategically focused on technology fields including AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [6]. - BGM Group utilizes big data mining and AI Agent technology to provide comprehensive AI solutions and intelligent robot services, particularly in the insurance sector [7]. - In biopharmaceuticals, the company produces key products like oxytetracycline API and crude heparin sodium, integrating AI-assisted decision-making to optimize production and supply chain processes [8].